Innoviva, Inc. Common Stock

INVANASDAQ • USD
19.03 USD
↗ 0.06 (0.32%)AT CLOSE (03:59 PM EST)
19.23
↗ 0.20 (1.03%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
19.23
↗ 0.20 (1.03%)
🔴Market: CLOSED

Innoviva, Inc. Common Stock (INVA) is currently trading at $19.03. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, INVA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$19.11
High?$19.23
Low?$18.95
Prev. Close?$18.97
Volume?560.9K
Avg. Volume?796.7K
VWAP?$19.06
Rel. Volume?0.70x
Bid / Ask
Bid?$18.85 × 100
Ask?$19.50 × 1.8K
Spread?$0.65
Midpoint?$19.18
Valuation & Ratios
Market Cap?1.4B
Shares Out?71.1M
Float?68.9M
Float %?95.4%
P/E Ratio?6.99
P/B Ratio?1.19
EPS?$2.72
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Employees
159
Market Cap
1.3B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2004-10-05
Address
1350 OLD BAYSHORE HIGHWAY
BURLINGAME, CA 94010
Phone: (650) 238-9600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
84
Momentum?
82
Short Sent.?
48
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.51Safe
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.88%High
Short Interest?7.5M
Days to Cover?12.9
Free Float68.9M
Avg Daily Volume582.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?15.44Strong
Quick Ratio?14.58Strong
Cash Ratio?11.62Strong
Debt/Equity?0.23Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
94/100
P/E?
Peers
100
S&P
97
7.0CHEAP▾
P/B?
Peers
100
S&P
93
1.19CHEAP▾
P/S?
Peers
100
S&P
49
3.09FAIR▾
P/FCF?
Peers
100
S&P
94
7.4CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
4.9CHEAP▾
EV/Sales?
Peers
100
S&P
70
2.35CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
60
17.0%STRONG▾
ROA?
Peers
50
S&P
82
12.6%STRONG▾
Cash Flow & Enterprise
FCF?$182.5M
Enterprise Value?$1.0B
Fundamentals ratios updated end of day